Clinical Trial

A Study of Olomorasib (LY3537982) in Healthy Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The main purpose of this study in healthy participants is to determine the effect of fluconazole on the amount of study drug that gets into the bloodstream and how long it takes the body to get rid of it. For each participant, the study will last up to approximately 7 weeks and will require 12 overnight stays in the research center.
Protocol Amendment History 1 change
critical Trial completed 2026-05-20
Trial Details
NCT Number NCT07439250
Lead Sponsor Eli Lilly and Company
Conditions Healthy
Enrollment 15 participants
Start Date 2026-03-02
Primary Completion 2026-04-17 (estimated)
Study Completion 2026-04-17 (estimated)
Updated on ClinicalTrials.gov 2026-05-19